Digital Health Intervention to Support Opioid Use Disorder Treatment
Key facts
- Who runs it
- Rhode Island Hospital
- Where
- Providence, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 1 Oct 2020
- Ended
- 15 Nov 2023
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- iENDURE
- Record updated
- 10 April 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- age 18+ years; current DSM-5 diagnosis of Opioid Use Disorder; current buprenorphine prescription; and access to cell phone with text message capability
Who cannot take part
- active suicidality and/or psychosis; not fluent in English; not having a phone data plan
Where in United States
- Rhode Island HospitalProvidence, United States
About the trial
What the trial wants to find out
In prior studies, the investigative team developed a combined computer- and text message-delivered personalized-feedback intervention (iENDURE) designed to enhance motivation and improve tolerance of distress to support the early phase of buprenorphine treatment. Specific aims of this subsequent study include conducting a preliminary randomized controlled trial with 80 participants to examine the efficacy of iENDURE relative to Treatment-as-Usual (TAU).
The 2 groups in the trial
- iENDURETreatment being tested
iENDURE involves two delivery modes: computer and text message. The intervention initially targets motivational processes in combination with introductory strategies for managing physical and emotional distress through a single, brief, computer-delivered session followed by eight weeks of theoretically-informed text messages intended to enhance motivation and promote distress tolerance (DT).
- Treatment-as-UsualNo study treatment, for comparison
Participants in the TAU comparison control group will engage in buprenorphine treatment as determined by their clinical team. This could include medication evaluations, individual or group counseling, case management or peer recovery. TAU was selected as the comparison condition as it represents a robust and evidence-based approach to the treatment of OUD.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- iENDURE: Digital Health Intervention to Support Opioid Use Disorder Treatment
- Publications
- Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder.Addiction science & clinical practice, 2020
- Record updated
- 10 April 2024